TrialNCT03093259Phase 2Completed
ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
Study sponsor: Abivax S.A. · ABVX
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2018-07-25Actual
Enrollment · participants32Actual
Source updated2024-06-03Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.